Homepage Header
For Healthcare Professionals
Hero_Banner
CRM image
CRM image

Innovation in care

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products

Explore our products

Holistic Cardio-Renal-Metabolic care

3.5x higher mortality in T2DM

For t2dm patients

CRM risk in India

3 out of 5 newly diagnosed T2DM cases at very high CVD risk.2
Learn more about T2DM
9.5% of India’s population

For CKD patients

Burden of CKD in India

Kidney disease significantly contributes to global morbidity and mortality.3
Learn more about CKD
HF CVD is the leading cause of death in India6

For HF patients

CVD Burden in India

Ischaemic heart disease and stroke vary across India, requiring urgent health action.6
Learn more about HF

Integrated management across interconnected risks

Why it matters:
  • The burden of cardiovascular disease and CKD remains high in T2DM patients
  • Delayed recognition of interconnected risks can lead to increased complications and mortality
  • Early, integrated intervention across CV, renal, and metabolic domains is essential
  • A holistic strategy enables better risk reduction and long-term patient outcomes
cardio renal metabolic risk management int2dm

Original research product

Bioequivalence and therapeutic equivalence are not similar8,9

Original research product

Latest insights & updates

Start now
Can you conquer the Glyxambi Octet A1c League?
Can you conquer the Glyxambi Octet A1c League?

Navigate diabetes management challenges, score points with every correct decision, and progress through the league as you work towards championship status.
Start now
Start now
Not all equations equate: making informed T2D treatment choices
Not all equations equate: making informed T2D treatment choices

Do all generics perform equally in everyday practice? Watch Dr. Peter Lin share practical insights into treatment decision-making and the role of a trusted option, beyond price considerations.
Start now
JARDIANCE®: A 4-time Prix-Galien award winner
JARDIANCE®: A 4-time Prix-Galien award winner

JARDIANCE®: A 4-time Prix-Galien award winner recognised for scientific innovation and impact on human health18

(Prix-Galien is regarded as Noble prize in pharmaceutical research and development)

Explore the Prix Galien journey

Abbreviations: CKD, chronic kidney disease; CRM, cardio-renal-metabolic; CV, cardiovascular; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; HF, heart failure; T2DM, type 2 diabetes mellitus.

  1. Anjana RM, Unnikrishnan R, Mugilan P, et al. Causes and predictors of mortality in Asian Indians with and without diabetes-10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES - 150). PLoS One. 2018;13(7):e0197376.

  2. Unnikrishnan AG, Sahay RK, Phadke U, et al. Cardiovascular risk in newly diagnosed type 2 diabetes patients in India. PLoS One. 2022;17(3):e0263619.

  3. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733.

  4. Xie Y, Bowe B, Mokdad AH, et al. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567-581.

  5. Ene-Iordache B, Perico N, Bikbov B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health. 2016;4(5):e307-e319.

  6. India state-level disease burden initiative CVD collaborators. The changing patterns of cardiovascular diseases and their risk factors in the states of India: The global burden of disease study 1990-2016. Lancet Glob Health. 2018;6(12):e1339-e1351.

  7. Johansson Bartolini I, Joseph P, Islam S, et al. Heart Failure Among 173,000 Community-Dwelling Participants From 25 Low-, Middle-, and High-Income Countries in the PURE Study. J Am Coll Cardiol. Published online April 22, 2026.

  8. Roy V, Rana P. Prescribing generics: All in a name. Indian J Med Res. 2018;147(5):442-444.

  9. Chow SC. Bioavailability and bioequivalence in drug development. Wiley Interdiscip Rev Comput Stat. 2014;6(4):304-312.

  10. Zou L, Ni Z, Tsakalozou E, Giacomini KM. Impact of pharmaceutical excipients on oral drug absorption: A focus on intestinal drug transporters. Clin Pharmacol Ther. 2019;105(2):323-325. 

  11. Subramaniam S, Kamath S, Ariaee A, Prestidge C, Joyce P. The impact of common pharmaceutical excipients on the gut microbiota. Expert Opin Drug Deliv. 2023;20(10):1297-1314.

  12. Martinez MN, Sinko B, Wu F, et al. A critical overview of the biological effects of excipients (part I): Impact on gastrointestinal absorption. AAPS J. 2022;24(3):60.

  13. Patel R, Barker J, ElShaer A. Pharmaceutical excipients and drug metabolism: A mini-review. Int J Mol Sci. 2020;21(21):8224.

  14. Martinez MN, Wu F, Sinko B, et al. A critical overview of the biological effects of excipients (part ii): scientific considerations and tools for oral product development. AAPS J. 2022;24(3):61.

  15. Abrantes CG, Duarte D, Reis CP. An overview of pharmaceutical excipients: safe or not safe?. J Pharm Sci. 2016;105(7):2019-2026.

  16. Comoglu T, Ozyilmaz ED. Pharmaceutical excipients in pediatric and geriatric drug formulations: safety, efficacy, and regulatory perspectives. Pharm Dev Technol. 2025;30(1):1-9.

  17. Noh IJ, Gray J, Ball G, et al. Are all generic drugs created equal? An empirical analysis of generic drug manufacturing location and serious adverse events. Prod Oper Manag. 2025;34(9):2601-2617.

  18. The Galien Foundation. Laureates Private Sector Since 1970. Accessed February 22, 2025. Available at: https://www.galienfoundation.org/laureates-worldwide

Picture/s used in this communication is/are of professional actors/models, used for representation/creative purposes, and are not of any actual patient or healthcare professional. Any resemblance to persons, living or dead is coincidental.